Wave Life Sciences Ltd/ SG9999014716 /
2024-05-03 10:00:00 PM | Chg. +0.2600 | Volume | Bid12:46:12 AM | Ask12:46:12 AM | High | Low |
---|---|---|---|---|---|---|
6.1400USD | +4.42% | 849,147 Turnover: 4.54 mill. |
5.5000Bid Size: 400 | 6.4800Ask Size: 200 | 6.3799 | 5.9000 |
GlobeNewswire
05-02
Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024
GlobeNewswire
04-30
Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial o...
GlobeNewswire
04-23
Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and R...
GlobeNewswire
03-06
Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business...
GlobeNewswire
02-28
Wave Life Sciences Fourth Quarter and Full Year 2023 Financial Results Scheduled for March 6, 2024
GlobeNewswire
02-27
Wave Life Sciences Announces Upcoming Presentations at MDA Conference that Highlight Best-in-Class P...
GlobeNewswire
01-03
US Neurologists Optimistic Regarding the Huntington’s Disease Treatment Pipeline, Emphasizing Haltin...
GlobeNewswire
2023-12-15
Wave Life Sciences Announces Initiation of Dosing in Phase 2 FORWARD-53 Trial of WVE-N531 in Duchenn...
GlobeNewswire
2023-12-06
Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants
GlobeNewswire
2023-12-06
Wave Life Sciences Announces Initiation of Dosing in RestorAATion Clinical Program Evaluating First-...
GlobeNewswire
2023-11-28
Codexis to Host Virtual KOL Event on its ECO Synthesis™ Platform and the Future of RNAi Therapeutics...
GlobeNewswire
2023-11-22
Wave Life Sciences to Present at 6ᵗʰ Annual Evercore ISI HealthCONx Conference
GlobeNewswire
2023-11-09
Wave Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire
2023-11-03
Wave Life Sciences Third Quarter 2023 Financial Results Scheduled for November 9, 2023
GlobeNewswire
2023-09-28
Wave Life Sciences Highlights Growth Strategy for Building the Leading RNA Medicines Company in Annu...
GlobeNewswire
2023-09-25
Wave Life Sciences to Present at the Chardan 7th Annual Genetic Medicines Conference
GlobeNewswire
2023-09-06
Wave Life Sciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference
GlobeNewswire
2023-09-05
Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-006, the First-e...
GlobeNewswire
2022-03-21
Athira Pharma Announces Appointment of Dr. Michael A. Panzara to its Board of Directors